Drug Delivery

(Image: Getty/Wavebreakmedia)

Q&A

Nemaura to debut 48-hour transdermal pain patch

By Ben Hargreaves

Ahead of the CPhI Worldwide in Madrid next week, Nemaura announced that it would be showcasing its newly developed 48-hour diclofenac transdermal patch and would be linking up with an unnamed global pharma company to develop three new products.

(Image: Getty/Victor_Tongdee)

Ketamine: The future treatment of severe mental illness?

By Maggie Lynch

In this first part of a two-part investigation, we look at how NDMA receptor antagonists, such as ketamine, could be poised to make a breakthrough in the treatment of depression – an area where the pharma industry has struggled to identify new targets...

Getty/Ninitta

Significant step taken towards insulin pill

By Ben Hargreaves

Researchers from Harvard University have developed an insulin formulation using two ionic liquids they say could lead to the development of a pill for diabetics.

(Image: Getty/Nordroden)

News in Brief

Visible particulates in drug vials spark US FDA recall

By Melissa Fassbender

The US FDA has issued a recall of non-expired products marketed as sterile made by Coastal Meds after an investigation of the outsourcing facility found poor sterile production practices.

Follow us

Products

View more

Webinars